This week, global editor Joe Chang looks at Apollo Management and Hexion Specialty Chemicals trying to cancel their acquisition of Huntsman, and pharma editor Feliza Mirasol, in conjunction with the special reports on India for the July 7 issue of ICIS Chemical Business, examines the improved R&D processes of India's pharmaceutical industry.
